BioCentury
ARTICLE | Product Development

Pitt delivers first peer-reviewed data for COVID-19 vaccine, to advance to clinic

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 2, 2020 6:40 PM UTC
Updated on Apr 3, 2020 at 2:27 AM UTC

In the first peer-reviewed publication for a COVID-19 vaccine headed for the clinic, University of Pittsburgh School of Medicine researchers showed their candidate induced in mice antibody titers thought to be enough for protection.

Pitt has already begun applying for an IND from FDA to begin Phase I testing of the product, PittCoVacc, within a few months. ...

BCIQ Company Profiles

University of Pittsburgh

BCIQ Target Profiles

Coronavirus S protein